The loss of Brg1 and/or Brm can enhance cancer development via the up-regulation (as measured by qPCR) of 26 potential cancer-promoting genes from at least 5 categories (angiogenesis, anti-apoptosis, cancer progression, metastasis and proliferation). The gene discussed is SMARCA2; the disease is cancer.